BACKGROUND: Schizophrenia is characterized by deficits in executive control and impairments in emotion processing. This study assessed the nature and extent of potential alterations in the neural substrates supporting the interaction between cognitive control mechanisms and emotion attribution processes in people with schizophrenia. METHODS: Functional magnetic resonance imaging was performed during a verbal emotional go/no-go task. People with schizophrenia and healthy controls responded to word stimuli of a prespecified emotional valence (positive, negative or neutral) while inhibiting responses to stimuli of a different valence. RESULTS: We enrolled 20 people with schizophrenia and 23 controls in the study. Healthy controls activated an extensive dorsal prefrontal-parietal network while inhibiting responses to negative words compared to neutral words, but showed deactivation of the midcingulate cortex while inhibiting responses to positive words compared to neutral words. People with schizophrenia failed to activate this network during response inhibition to negative words, whereas during response inhibition to positive words they did not deactivate the cingulate, but showed increased responsivity in the frontal cortex. LIMITATIONS: Sample heterogeneity is characteristic of studies of schizophrenia and may have contributed to more variable neural responses in the patient sample despite the care taken to control for potentially confounding variables. CONCLUSION: Our results showed that schizophrenia is associated with aberrant modulation of neural responses during the interaction between cognitive control and emotion processing. Failure of the frontal circuitry to regulate goal-directed behaviour based on emotion attributions may contribute to deficits in psychosocial functioning in daily life.
BACKGROUND:Schizophrenia is characterized by deficits in executive control and impairments in emotion processing. This study assessed the nature and extent of potential alterations in the neural substrates supporting the interaction between cognitive control mechanisms and emotion attribution processes in people with schizophrenia. METHODS: Functional magnetic resonance imaging was performed during a verbal emotional go/no-go task. People with schizophrenia and healthy controls responded to word stimuli of a prespecified emotional valence (positive, negative or neutral) while inhibiting responses to stimuli of a different valence. RESULTS: We enrolled 20 people with schizophrenia and 23 controls in the study. Healthy controls activated an extensive dorsal prefrontal-parietal network while inhibiting responses to negative words compared to neutral words, but showed deactivation of the midcingulate cortex while inhibiting responses to positive words compared to neutral words. People with schizophrenia failed to activate this network during response inhibition to negative words, whereas during response inhibition to positive words they did not deactivate the cingulate, but showed increased responsivity in the frontal cortex. LIMITATIONS: Sample heterogeneity is characteristic of studies of schizophrenia and may have contributed to more variable neural responses in the patient sample despite the care taken to control for potentially confounding variables. CONCLUSION: Our results showed that schizophrenia is associated with aberrant modulation of neural responses during the interaction between cognitive control and emotion processing. Failure of the frontal circuitry to regulate goal-directed behaviour based on emotion attributions may contribute to deficits in psychosocial functioning in daily life.
Authors: John G Kerns; Jonathan D Cohen; Angus W MacDonald; Raymond Y Cho; V Andrew Stenger; Cameron S Carter Journal: Science Date: 2004-02-13 Impact factor: 47.728
Authors: Ute Habel; Katharina Pauly; Kathrin Koch; Thilo Kellermann; Martina Reske; Volker Backes; Tony Stöcker; Katrin Amunts; N Jon Shah; Frank Schneider Journal: World J Biol Psychiatry Date: 2010-07-20 Impact factor: 4.132
Authors: David E Gard; Shanna Cooper; Melissa Fisher; Alexander Genevsky; Joseph A Mikels; Sophia Vinogradov Journal: Psychiatry Res Date: 2011-01-14 Impact factor: 3.222
Authors: Christian G Kohler; Travis H Turner; Warren B Bilker; Colleen M Brensinger; Steven J Siegel; Stephen J Kanes; Raquel E Gur; Ruben C Gur Journal: Am J Psychiatry Date: 2003-10 Impact factor: 18.112
Authors: Stephen M Strakowski; Caleb M Adler; Michael A Cerullo; James C Eliassen; Martine Lamy; David E Fleck; Jing-Huei Lee; Melissa P DelBello Journal: Early Interv Psychiatry Date: 2008-11 Impact factor: 2.732
Authors: Andrew R Mayer; Faith M Hanlon; Andrew B Dodd; Ronald A Yeo; Kathleen Y Haaland; Josef M Ling; Sephira G Ryman Journal: J Psychiatry Neurosci Date: 2016-08 Impact factor: 6.186
Authors: Keith M Shafritz; Toshikazu Ikuta; Allison Greene; Delbert G Robinson; Juan Gallego; Todd Lencz; Pamela DeRosse; Peter B Kingsley; Philip R Szeszko Journal: Brain Imaging Behav Date: 2019-04 Impact factor: 3.978
Authors: Andrew R Mayer; Faith M Hanlon; Terri M Teshiba; Stefan D Klimaj; Josef M Ling; Andrew B Dodd; Vince D Calhoun; Juan R Bustillo; Trent Toulouse Journal: Br J Psychiatry Date: 2015-09-17 Impact factor: 9.319
Authors: Jie-Yu Chuang; Kirstie J Whitaker; Graham K Murray; Rebecca Elliott; Cindy C Hagan; Julia Me Graham; Cinly Ooi; Roger Tait; Rosemary J Holt; Adrienne O van Nieuwenhuizen; Shirley Reynolds; Paul O Wilkinson; Edward T Bullmore; Belinda R Lennox; Barbara J Sahakian; Ian Goodyer; John Suckling Journal: J Affect Disord Date: 2015-09-11 Impact factor: 4.839
Authors: A Vercammen; C S Weickert; A J Skilleter; R Lenroot; P R Schofield; T W Weickert Journal: Transl Psychiatry Date: 2014-02-04 Impact factor: 6.222